Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Non-Current Assets (2021 - 2025)

PAVmed (PAVM) has 5 years of Non-Current Assets data on record, last reported at $3.4 million in Q3 2025.

  • For Q3 2025, Non-Current Assets changed N/A year-over-year to $3.4 million; the TTM value through Sep 2025 reached $3.4 million, changed N/A, while the annual FY2024 figure was $5.6 million, 35.43% down from the prior year.
  • Non-Current Assets reached $3.4 million in Q3 2025 per PAVM's latest filing, down from $4.8 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $13.3 million in Q1 2022 and bottomed at $861000.0 in Q1 2021.
  • Average Non-Current Assets over 5 years is $7.1 million, with a median of $7.7 million recorded in 2024.
  • Peak YoY movement for Non-Current Assets: soared 1448.43% in 2022, then tumbled 47.46% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $4.3 million in 2021, then skyrocketed by 131.71% to $10.1 million in 2022, then dropped by 14.25% to $8.6 million in 2023, then plummeted by 35.43% to $5.6 million in 2024, then tumbled by 39.72% to $3.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Assets were $3.4 million in Q3 2025, $4.8 million in Q2 2025, and $5.3 million in Q1 2025.